| Dr Philip G Woodham, | |
|
20 Prospect Ave, Suite 715, Hackensack, NJ 07601-1997 | |
| (201) 881-0721 | |
| (201) 881-0725 |
| Full Name | Dr Philip G Woodham |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 20 Prospect Ave, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174667836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MA67550 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Hackensack, NJ | Home health agency |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Palisades Medical Center | North bergen, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Primary Care Pc | 7911003330 | 273 |
News Archive
In a study published in the current issue of
"We must not let the conversation about healthcare reform become derailed by confusion. If real reform is to take place it must include a public option.
From middle-age onwards, the brains of people who are obese or overweight exhibit differences in white matter similar to lean individuals who are 10 years their senior, according to researchers from the University of Cambridge.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.
› Verified 4 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
In a study published in the current issue of
"We must not let the conversation about healthcare reform become derailed by confusion. If real reform is to take place it must include a public option.
From middle-age onwards, the brains of people who are obese or overweight exhibit differences in white matter similar to lean individuals who are 10 years their senior, according to researchers from the University of Cambridge.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.
› Verified 4 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Primary Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336203538 PECOS PAC ID: 7911003330 Enrollment ID: O20070502000000 |
News Archive
In a study published in the current issue of
"We must not let the conversation about healthcare reform become derailed by confusion. If real reform is to take place it must include a public option.
From middle-age onwards, the brains of people who are obese or overweight exhibit differences in white matter similar to lean individuals who are 10 years their senior, according to researchers from the University of Cambridge.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Philip G Woodham, 452 Old Hook Rd, 2nd Floor, Emerson, NJ 07630-1381 Ph: (201) 666-3900 | Dr Philip G Woodham, 20 Prospect Ave, Suite 715, Hackensack, NJ 07601-1997 Ph: (201) 881-0721 |
News Archive
In a study published in the current issue of
"We must not let the conversation about healthcare reform become derailed by confusion. If real reform is to take place it must include a public option.
From middle-age onwards, the brains of people who are obese or overweight exhibit differences in white matter similar to lean individuals who are 10 years their senior, according to researchers from the University of Cambridge.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.
› Verified 4 days ago
Dr. Sean Shabbir Sadikot, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Dr. Noa Biran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-8704 Fax: 551-996-0582 | |
Naresh Chanderi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |